Agenus reported $290.48M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Agenus AGEN:US $ 290.48M 41.49M
Amgen AMGN:US $ 19322M 802M
AstraZeneca AZN:LN 20.92B 1.73B
Bristol Myers Squibb BMY:US $ 30186M 65M
Celldex Therapeutics CLDX:US $ 390.7M 20.14M
Chemocentryx CCXI:US $ 351.63M 82.46M
CSL CSL:AU $ 12.46B 5.07B
Dynavax Technologies DVAX:US $ 955.4M 14.89M
Eli Lilly And LLY:US $ 17115.2M 150.5M
Genocea Biosciences GNCA:US $ 24.41M 17.41M
Gilead Sciences GILD:US $ 13705M 1076M
GlaxoSmithKline GSK:LN 54.19B 25.2B
Glaxosmithkline GSK:US $ 54188M 25200M
Immunogen IMGN:US $ 373.87M 82.84M
Intrexon XON:US $ 154.94M 1.69M
Jiangsu Hengrui Me. 600276:CH CH 30.49B 305.23M
Karyopharm Therapeutics KPTI:US $ 242.45M 34.09M
Macrogenics MGNX:US $ 218.2M 61.36M
Northwest Biotherapeutics NWBO:US 9.27M 8.02M
Novartis NOVN:VX 38.14B 906M
Novavax NVAX:US $ 2347.41M 192.29M
Regeneron Pharmaceuticals REGN:US $ 15529.9M 1223.9M
Rigel Pharmaceuticals RIGL:US $ 120.52M 18.42M
Sangamo Biosciences SGMO:US $ 343.12M 3.06M
Veracyte VCYT:US $ 235.04M 3.44M
YTE INCY:US $ 3625.84M 337.75M